Spectrum of Seasonal Allergic Rhinitis Symptom Relief with Topical Corticoid and Oral Antihistamine Given Singly or in Combination
- 1 May 1996
- journal article
- research article
- Published by SAGE Publications in American Journal of Rhinology
- Vol. 10 (3) , 193-200
- https://doi.org/10.2500/105065896781794941
Abstract
Sixty ragweed-sensitive volunteers participated in a 2-week study that compared symptom profiles during treatment with antihistamine (loratadine, LOR) alone, topical corticoid (beclomethasone, BEC) alone, or the two drugs combined. For 5 days commencing shortly after the beginning of the ragweed bloom, patients took no treatment while we collected baseline data. They were then randomized to one of the three treatments, receiving that treatment for the balance of the 2-week study term. Twice each day they recorded the severity of congestion, eye symptoms, running and blowing, itching, and sneezing. At the end of the study they provided an estimate of overall symptom relief, which favored combined treatment (vs LOR P = 0.001, vs BEC P = 0.042). To gain an estimate of disease severity and treatment effectiveness over time, and to smooth out day-to-day variation, we divided symptom diary reports into three segments (days 2–4, 5–7, and 8–10) for analysis. Combined treatment controlled symptoms better than antihistamine alone in nearly all study segments. Corticoid alone or combined with antihistamine provided similar control of congestion, running and blowing, and eye complaints. Combination therapy controlled itching and sneezing better, especially through the study segments 1 and 2. Patient preference for combined treatment seems to relate to control of itching and sneezing and rapid onset of effect.Keywords
This publication has 6 references indexed in Scilit:
- Oral Methylprednisolone Acetate (Medrol Tablets) for Seasonal Rhinitis: Examination of Dose and Symptom ResponseThe Journal of Clinical Pharmacology, 1993
- Profile of ragweed hay fever symptom control with terfenadine started before or after symptoms are establishedClinical and Experimental Allergy, 1990
- Dexamethasone Does Not Inhibit the Release of Mediators from Human Mast Cells Residing in Airway, Intestine, or SkinAmerican Review of Respiratory Disease, 1989
- Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitisJournal of Allergy and Clinical Immunology, 1989
- Nasal Mucosal Mast Cells and Histamine in Hay FeverInternational Archives of Allergy and Immunology, 1987
- Effect of beclomethasone dipropionate on nasal metachromatic cell sub‐populationsClinical and Experimental Allergy, 1986